Base Year: 2018
Estimated Year: 2019
Forecast Period: 2019 to 2026
Market Insights
The study projects that the Intravenous Anesthetic market will register a xxxx% CAGR in terms of revenue, which is expected to reach USD xxxx million in 2026 from USD xxxx million in 2019. The market growth is mainly attributed to factors such as the increase in the number of surgical interventions requiring anesthesia, a rising in awareness about delirium, and predictable nature of these drugs. Furthermore, the rising number of geriatric populations coupled with increasing number of chronic diseases such as cancer, cardiovascular, neurological, and respiratory disorders and the introduction of advanced anesthesia are factors that driving market growth. On the contrary side, adverse side effects during recovery, procedure or surgery are considered as restraint factor for market growth.
North America dominates the market and expected to maintain its dominance during the forecast period. The rising number of plastic surgeries and substantially increasing the adoption rate of the process will drive the business growth in U.S. Furthermore, the presence of associations that aids in maintaining the standards of anesthesiology will fuel the industry growth in the country. The Asia Pacific market is expected to register a high growth rate during the forecast period owing to the large surgical patient pool, developing healthcare infrastructure, and rising healthcare tourism in countries like India.
Intravenous anesthetics are used to induce a state of impaired awareness or for complete sedation. Commonly used intravenous anesthetics include propofol, etomidate, ketamine, and barbiturates (e.g., thiopental).
Get FREE Sample of Intravenous Anesthetic Market Report at:
Competitive Outlook
The major global Intravenous Anesthetic market competitors include AstraZeneca, Fresenius-Kabi, BbVie Laboratories, Baxter Healthcare, Braun, Maruishi, Piramal Healthcare, Hikma Pharmaceuticals, Mylan, Nhwa, Lunan, Hengrui, etc.
Type Outlook
• Tetrazolium
• Ketamine
• Sodium Oxybate
• Others
Application Outlook
• Hospital Use
• Clinic Use
• Other Use
Purchase a copy of Intravenous Anesthetic report at:
Regions Covered in the Report:
North America
• United States
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Italy
• Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
• Spain
• Belgium
• Poland
• Russia
• Turkey
• Others
Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia and New Zealand
• ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)
Latin America, Middle East & Africa
• GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
• Brazil
• Nigeria
• South Africa
• Argentina
• Others
Ask for a discount at:
The research report provides in-depth analysis on:
• The estimation of the growth rate, market size and share of the Intravenous Anesthetic Market throughout the forecast period.
• The assessments for the regional market layout characteristics in the world.
• The SWOT of the Intravenous Anesthetic Market.
• Leading manufacturers’ profiles, product features, business features, target customer features.
• Significant trends for the growth prospects of the Intravenous Anesthetic Market by 2026.
• The report tracks detailed information about merges, innovations, policies and recent developments in the industry.
Contact:
Global Market Monitor
One Pierrepont Plaza, 300 Cadman Plaza W, Brooklyn,
NY 11201, USA
Phone: + 1 (347) 467 7721
Email: info@globalmarketmonitor.com
Web Site: https://www.globalmarketmonitor.com
We provide more professional and intelligent market reports to complement your business decisions.
Chinese